Submission Instruction

Submission
Manuscripts should be submitted online using the “Submission Form” section on the journal’s homepage http://pbr.mazums.ac.ir/ and it's process is free of charge . Manuscripts must be created in Microsoft Word. This journal does not accept manuscripts that are simultaneously being considered by another or other journals or already published elsewhere. Similarly, this journal requires the following statement provided in the Comments to the Editor in a cover letter: “This manuscript submitted has not been previously published, nor is it before another journal for consideration"
Manuscript preparation
Typing: Manuscripts should be written in clear English language. Manuscripts must be typewritten in a font size of 12 points, Times New Roman, double-spaced (including References, Tables and Figure legends) with wide margins (2.5 cm from all sides) on one side of A4 paper. The beginning of each new paragraph must be clearly indicated by indentation. All pages should be numbered consecutively at the bottom starting with the title page.
The manuscript should include:
Title page
Abstract
Introduction
Materials and methods
Results
Discussion/ Conclusion
Acknowledgement
References
Tables and figures

Title page: Write a brief and informative title that identifies the nature of the subject matter. Avoid chemical formulas, Symbols, or arbitrary abbreviations, except chemical symbols to indicate the structure of isotopically labeled compounds. The name of all authors, including the first and last names; their affiliation, the department and institutional affiliation of each author should be numbered and addressed. Put * above the corresponding author and give telephone number, fax number and email ID in the footer.

Abstract: All manuscripts must accompany abstract up to 250 words. The abstract should be concise and briefly describe the purpose of the work, techniques and methods used, major findings with important data and principal conclusions.

Keywords: A list of 3-5 keywords should be included below the abstract. Use terms from the Medical Subject Headings (MESH) list of index medicus (http://www.nlm.nih.gov/mesh/MBrowser.html). If suitable MESH terms are not yet available for recently introduced terms, present terms may be used.

Introduction: This should contain a description of the problem under investigation and relevant background information and published studies should be described concisely, and be cited appropriately. It should neither review the subject extensively nor should it have data or conclusions of the study.

Materials and methods: Give adequate information to allow the experiment to be reproduced. Already published methods should be mentioned with references. Significant modifications of published methods and new methods should be described in detail. This section will include sub-sections.

Results: Results should provide detailed response rates. It is essential to include statistical analyses or other indicators to enable assessment of the variance of replicates of the experiments. Tables and figures should be submitted separately as files.

Discussion: The discussion should not repeat the results, but provide detailed interpretation of data. This should interpret the significance of the findings of the work. The discussion about the tables and figures should appear in the text before the appearance of the respective tables and figures. No tables or figures should be given without discussion or reference inside the text.

Conclusions: This should emphasize the new and important aspects of the studyand the variations or similarities with other work done in the field by other workers.

Acknowledgments: This optional part should include a statement thanking those who assisted substantially with work relevant to the study. Grant support should be included in this section.

Conflict of interests: Any information regarding the potential conflict of interests related to various aspects such as financial support by commercial firms, etc… should be disclosed in manuscripts to help clarify this issue. Declaring a competing interest will not lead to automatic rejection of the paper, but we would like to be made aware of it.

References: References must be double-spaced and numbered consecutively as they are cited. References first cited in a table or figure legend should be numbered so that they will be in sequence with references cited in the text at the point where the table or figure is first mentioned. List all authors when there are six or fewer; when there are seven or more, list the first six, followed by “et al.” (Vancouver reference style). The following are sample references:

(Click to download endnote format)

Journal:
Tajon C, Jun YW, Craik CS. Single-molecule sensing of caspase activation in live cells via plasmon coupling nanotechnology. Methods Enzymol 2014;544:271-97.

Book:
Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, Kasper DL, et al, editors. Harrison’s principles of internal medicine. 14th ed. New York: McGraw Hill, Health Professions Division; 1998.

Book Chapter:
Porter RJ, Meldrum BS. Antiepileptic drugs. In: Katzung BG, editor. Basic and clinical pharmacology. 6th ed. Norwalk (CN): Appleton and Lange; 1995. p. 361-80.

Conference Papers:
Bengtsson S, Solheim BG. Enforcement of data protection, privacy and security in medical informatics. In: Lun KC, Degoulet P, Piemme TE, Reinhoff O, editors. MEDINFO 92.Proceedings of the 7th World Congress on Medical Informatics; 1992 Sep 6-10; Geneva, Switzerland. Amsterdam: North-Holland; 1992. p. 1561-5.

Web Site:
Garfinkel PE, Lin E, Goering P. Should amenorrhoea be necessary for the diagnosis of anorexia nervosa? Br J Psych [serial online] 1996 [cited 1999 Aug 17]; 168(4):500-6. Available from: URL:http://biomed.niss.ac.uk

Tables: Table headings should be placed above the table. The Tables should provide easier understanding and not duplicate information already included in the text or figures. They should be numbered (1, 2, 3, etc.) as they appear in the text.

Figures: All figures should be in JPG, TIFF and GIF formats. The name and footnote of the figure should not be included in it. They should be included only if they augment understandability of the text. Structures should be produced with the use of a drawing program such as ChemDraw. Drawings and graphs should be professionally prepared in deep-black and submitted as glossy, black-and-white clean photostats. Professionally Illustrations should be numbered as cited in the sequential order in the text, and each should have a legend on a separate sheet. Color photographs are welcome at no extra charge.

Revision: Papers may be returned to authors for modification of the scientific content and/or for shortening and language corrections. Revised version should be sent by electronic word type file to pbr@mazums.ac.ir. If a paper that is returned to the authors for modification is not resubmitted within two months, it will be regarded as having been withdrawn and any revised version received subsequently will be treated as a new submission.

Proof Reading: Proofs will be sent to the corresponding author to be checked for only typographical errors and other essential small changes. Major alterations to the text can not be accepted at this stage. No changes in the name of the authors is permissible at this stage. Proofs must be returned to the Editor within 5 days of receipt.

Reprints: PDF electronically file of article will be sent to the corresponding author free of charge. Additional copies can be ordered at prices shown on the reprint order form.

Abbreviations and symbols: Use only standard abbreviations. Avoid using them in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.

Ethical guidelines: When reporting studies on human indicate whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/en/20activities/10ethics/index.html and http://www.wma.net/en/20activities/20humanrights/index.html). Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of anesthetics and analgesics used should be clearly stated. The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section.

 Plagiarism detection: It is the responsibility of every author who submits a manuscript to PBR to avoid plagiarism and duplicate publication. PBR is committed to deterring plagiarism, including self-plagiarism. It is the responsibility of editors, referees, and members of PBR editorial boards to ensure that the highest standards of authorial integrity are maintained. Plagiarism will abort reviewing process and Plagiarism is not acceptable in PBR.

Page charges: There are no charges for publication in this journal. There is no charge for manuscript processing and publication and there is no charge for readers to read, subscribe, copy, print, and download.

 
Submission form:

All articles published by Pharmaceutical and Biomedical Research are open access and made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers .

Authors should sign a submission form (Copyright assignment form- PBR) stating that the article is an original work, has not been published before and is not being considered for publication elsewhere in its final form either in printed or electronic form. The same research must not be published in more than one journal. If a manuscript contains any previous published image or text, it is the responsibility of the author to obtain authorization from copyright holders.



Write the security code in the box    
View: 2987 Time(s)   |   Print: 314 Time(s)   |   Email: 0 Time(s)   |   0 Comment(s)

© 2015 All Rights Reserved | Pharmaceutical and Biomedical Research

Designed & Developed by : Yektaweb